Such differences may underlie the epidemiological differences observed between MC1R and CDKN2A and skin cancer susceptibility since MC1R polymorphisms are involved in both CMM and NMSC susceptibility while CDKN2A mutations are closely related to CM susceptibility rather than SCC susceptibility. Here, MC1R is linked to skin neoplasm.